20. Adrenoleukodystrophy Clinical trials / Disease details
Clinical trials : 61 / Drugs : 90 - (DrugBank : 31) / Drug target genes : 23 - Drug target pathways : 126
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05003648 (ClinicalTrials.gov) | September 2021 | 15/7/2021 | Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy | Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy: A Key to Improving Sleep and Gait Performance | Adrenoleukodystrophy;Restless Legs Syndrome | Drug: Pramipexole;Drug: Placebo | Massachusetts General Hospital | European Leukodystrophy Association | Not yet recruiting | 18 Years | 75 Years | Female | 24 | Phase 4 | United States;Netherlands |